TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35984848

Group type: EXPERIMENTAL
Intervention: Reduced load (80% body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Normal load (100% body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Increased load (120% body weight)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Follow-up assessments at 24 months
Number of subjects: 0
Study: 32007523

Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy (IPL) - five flashes
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Intense pulsed light therapy (IPL) - four flashes
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 87
Study: 33371056

Group type: EXPERIMENTAL
Intervention: BCI-FES
Number of subjects: 25

Group type: COMPARATOR
Intervention: FES
Number of subjects: 25
Study: 35275009

Group type: EXPERIMENTAL
Intervention: Diperoxochloric acid (DPOCL)
Number of subjects: 289

Group type: COMPARATOR
Intervention: Isotonic sodium chloride solution (ISCL)
Number of subjects: 289
Study: 32345957

Group type: EXPERIMENTAL
Intervention: Contrast-Enhanced Ultrasound (CEUS)
Number of subjects: 68

Group type: COMPARATOR
Intervention: Intraoperative Neurophysiological Monitoring (IONM)
Number of subjects: 68
Study: 36322845

Group type: EXPERIMENTAL
Intervention: Amino acids at a dose of 1 g per day for 5 days after birth
Number of subjects: 434

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 434
Study: 34582448

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy; 10 ml applied 3 times daily throughout the neonatal period.
Number of subjects: 26487

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy (exclusive applications).
Number of subjects: 26487

Group type: EXPERIMENTAL
Intervention: Sunflower seed oil (SSO) emollient therapy (subgroup of infants weighing ≤1,500 g).
Number of subjects: 26487

Group type: COMPARATOR
Intervention: Mustard oil massage (usual care in comparison clusters).
Number of subjects: 26487
Study: 34233350

Group type: EXPERIMENTAL
Intervention: 0.1% Dakin's Solution (DS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 0
Study: 32458301

Group type: EXPERIMENTAL
Intervention: Condomless sex acts
Number of subjects: 5012

Group type: EXPERIMENTAL
Intervention: Sex acts with primary partners
Number of subjects: 5012

Group type: COMPARATOR
Intervention: Sex acts with condoms
Number of subjects: 5012

Group type: COMPARATOR
Intervention: Sex acts with non-primary partner
Number of subjects: 5012

Group type: EXPERIMENTAL
Intervention: Count of sexual risk behaviors among different groups (WSM, MSW, MSM)
Number of subjects: 5012
Study: 32737450

Group type: EXPERIMENTAL
Intervention: Adjuvant fluorouracil–levamisole in pMMR patients
Number of subjects: 544

Group type: COMPARATOR
Intervention: Surgery-only group in pMMR patients
Number of subjects: 544

Group type: COMPARATOR
Intervention: Chemotherapy group in pMMR patients
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: pMMR/CDX2-negative cases
Number of subjects: 544

Group type: EXPERIMENTAL
Intervention: pMMR patients with CDX2 negativity
Number of subjects: 544
Study: 616609856

Group type: EXPERIMENTAL
Intervention: Text message reminders sent to patients (320 patients)
Number of subjects: 641

Group type: COMPARATOR
Intervention: No text message reminders (321 patients)
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Text message reminders
Number of subjects: 641

Group type: EXPERIMENTAL
Intervention: Patients older than 50 years
Number of subjects: 641
Study: 35103604

Group type: EXPERIMENTAL
Intervention: Expert teleconsultations with intensivists and infectious disease specialists, available 24/7/365, once per week.
Number of subjects: 159424

Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 159424
Study: 34814835

Group type: EXPERIMENTAL
Intervention: Expert-based medication review with recommendations for drug discontinuation
Number of subjects: 579

Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 579

Group type: EXPERIMENTAL
Intervention: Expert-based medication review
Number of subjects: 579
Study: 33493893

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided vacuum-assisted biopsy (UGVAB)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Surgical resection (SR)
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Both UGVAB and SR
Number of subjects: 39
Study: 32447634

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG)
Number of subjects: 44
Study: 35737384

Group type: EXPERIMENTAL
Intervention: Laparoscopy-assisted colectomy (LAC)
Number of subjects: 943

Group type: COMPARATOR
Intervention: Open colectomy (OC)
Number of subjects: 943
Study: 32763619

Group type: EXPERIMENTAL
Intervention: Legal cynicism measurement
Number of subjects: 2680

Group type: EXPERIMENTAL
Intervention: Legal cynicism antecedents
Number of subjects: 2680
Study: 33941123

Group type: EXPERIMENTAL
Intervention: Work-related medical rehabilitation program (at least 11 hours of work-related treatment modules)
Number of subjects: 1800

Group type: COMPARATOR
Intervention: Conventional psychosomatic rehabilitation program
Number of subjects: 1800
Study: 32007177

Group type: EXPERIMENTAL
Intervention: Focused extracorporeal shockwave therapy
Number of subjects: 79

Group type: COMPARATOR
Intervention: Radial pressure wave therapy
Number of subjects: 79
Study: 32101504

Group type: EXPERIMENTAL
Intervention: High-intensity exercise program (5 weeks, 19 sessions, 60 mins each)
Number of subjects: 58
Study: 33151615

Group type: EXPERIMENTAL
Intervention: 0.05% tomato lycopene and 3.45% wheat bran extract cream applied twice a day for three months with SPF 30 sunscreen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo cream applied twice a day for three months with SPF 30 sunscreen
Number of subjects: 22
Study: 33197213

Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 280

Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 280
Study: 32036959

Group type: COMPARATOR
Intervention: HELP diet
Number of subjects: 144

Group type: EXPERIMENTAL
Intervention: HELP + RSV diet (400 mg/kg)
Number of subjects: 144

Group type: COMPARATOR
Intervention: Con diet
Number of subjects: 144
Study: 35428645

Group type: EXPERIMENTAL
Intervention: Digital behavioural health treatment for chronic pain
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 180
Study: 33482873

Group type: EXPERIMENTAL
Intervention: POCUS (point-of-care ultrasound) group
Number of subjects: 165

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165

Group type: EXPERIMENTAL
Intervention: POCUS group
Number of subjects: 165
Study: 32854200

Group type: EXPERIMENTAL
Intervention: Unified Protocol, delivered in an online group format
Number of subjects: 60
Study: 35396432

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 33493453

Group type: EXPERIMENTAL
Intervention: Edoxaban
Number of subjects: 12071

Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 12071
Study: 32164906

Group type: EXPERIMENTAL
Intervention: FOLFOXIRI plus bevacizumab
Number of subjects: 679

Group type: COMPARATOR
Intervention: mFOLFOX6 plus bevacizumab followed by FOLFIRI plus bevacizumab
Number of subjects: 679
Study: 35264337

Group type: EXPERIMENTAL
Intervention: Internet-based cognitive-behavioural writing therapy (iCBT)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 34
Study: 33809130

Group type: EXPERIMENTAL
Intervention: Flaxseed (FS) dietary intervention, 10 g/d for 6 weeks
Number of subjects: 252
Study: 32088670

Group type: EXPERIMENTAL
Intervention: Eucalyptus solution 5% inhalation 3 times/day for 20 minutes (every 8 hours)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Distilled water inhalation 3 times/day for 20 minutes (every 8 hours)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Eucalyptus solution 5% inhalation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Distilled water inhalation
Number of subjects: 100
Study: 34898009

Group type: EXPERIMENTAL
Intervention: e-learning (IG)
Number of subjects: 88

Group type: COMPARATOR
Intervention: no e-learning (CG)
Number of subjects: 88
Study: 33672666

Group type: EXPERIMENTAL
Intervention: Slowly processed pasta
Number of subjects: 14

Group type: COMPARATOR
Intervention: Normally processed pasta
Number of subjects: 14
Study: 35995135

Group type: EXPERIMENTAL
Intervention: Sulfadoxine-pyrimethamine (SP) plus artesunate
Number of subjects: 305

Group type: EXPERIMENTAL
Intervention: Amodiaquine (AQ) plus artesunate
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control (no malaria treatment)
Number of subjects: 305
Study: 33724643

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Supportive Psychotherapy (SPT)
Number of subjects: 120
Study: 32665529

Group type: EXPERIMENTAL
Intervention: Abaloparatide followed by alendronate
Number of subjects: 56

Group type: COMPARATOR
Intervention: Placebo followed by alendronate
Number of subjects: 56
Study: 36207685

Group type: EXPERIMENTAL
Intervention: Health-Social Partnership Program (HSPP) with nurse-led case management and support from a social service team.
Number of subjects: 92

Group type: EXPERIMENTAL
Intervention: Health-Social Partnership Program (HSPP)
Number of subjects: 92
Study: 33948660

Group type: EXPERIMENTAL
Intervention: Compassion meditation (CM) program delivered by smartphone application
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Compassion meditation (CM) program
Number of subjects: 57

Group type: COMPARATOR
Intervention: Compassion meditation (CM) group
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo condition (oxytocin)
Number of subjects: 57

Group type: COMPARATOR
Intervention: Familiarity condition
Number of subjects: 57
Study: 36482231

Group type: EXPERIMENTAL
Intervention: 2 μg/kg alfentanil
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 3 μg/kg alfentanil
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: 4 μg/kg alfentanil
Number of subjects: 300

Group type: COMPARATOR
Intervention: 0.9% saline (control group A)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: Increasing doses of alfentanil (2, 3, 4 μg/kg)
Number of subjects: 300

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 300
Study: 33988896

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle interventions (ILIs)
Number of subjects: 5145

Group type: COMPARATOR
Intervention: Diabetes support and education (Control)
Number of subjects: 5145
Study: 32967598

Group type: EXPERIMENTAL
Intervention: Routine drain insertion
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Seldom inserted drains
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Concerns about bleeding and anticoagulation
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Routine practice
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Volume and time for drain removal
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Volume alone for drain removal
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Volume threshold for drain removal
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Postoperative period for drain removal
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Consideration for randomized controlled trial
Number of subjects: 43
Study: 36137676

Group type: EXPERIMENTAL
Intervention: QFR-guided PCI
Number of subjects: 3825

Group type: COMPARATOR
Intervention: Angiography-guided PCI
Number of subjects: 3825

Group type: EXPERIMENTAL
Intervention: QFR-guided PCI (deferred)
Number of subjects: 3825
Study: 33676572

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (diet, exercise, cognitive training, and vascular risk management)
Number of subjects: 47

Group type: COMPARATOR
Intervention: General health advice (control group)
Number of subjects: 47
Study: 35688164

Group type: EXPERIMENTAL
Intervention: tixagevimab-cilgavimab 600 mg (two consecutive 3 mL intramuscular injections, 300 mg tixagevimab and 300 mg cilgavimab)
Number of subjects: 910

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 910

Group type: EXPERIMENTAL
Intervention: tixagevimab-cilgavimab 600 mg
Number of subjects: 910
Study: 35251938

Group type: EXPERIMENTAL
Intervention: 12-week web-based self-help intervention
Number of subjects: 152

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 152
Study: 32334703

Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg or 600 mg loading dose, then 75 mg once daily for 12 months)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Ticagrelor (180 mg loading dose, then 90 mg twice daily for 12 months)
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Ticagrelor
Number of subjects: 1002
Study: 36254029

Group type: EXPERIMENTAL
Intervention: Religious Rational Emotive Behavior Therapy (RREBT) for 12 weeks
Number of subjects: 67

Group type: COMPARATOR
Intervention: Control condition (no intervention)
Number of subjects: 67
Study: 32964915

Group type: EXPERIMENTAL
Intervention: Altruism frame emphasizing local impact
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Altruism frame emphasizing national impact
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Anxiety induction
Number of subjects: 1267

Group type: EXPERIMENTAL
Intervention: Compassion induction
Number of subjects: 1267

Group type: COMPARATOR
Intervention: Neutral condition
Number of subjects: 1267
Study: 35412049

Group type: EXPERIMENTAL
Intervention: Full face mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Half mask
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Snorkelling mask
Number of subjects: 30
Study: 33034015

Group type: EXPERIMENTAL
Intervention: Intra-gastric balloon (IGB) therapy
Number of subjects: 99
Study: 35023284

Group type: EXPERIMENTAL
Intervention: Immediate ART (n=477)
Number of subjects: 954

Group type: COMPARATOR
Intervention: Deferred ART (n=477)
Number of subjects: 954
Study: 33491480

Group type: EXPERIMENTAL
Intervention: Suture Tape (ST)
Number of subjects: 119

Group type: COMPARATOR
Intervention: Modified Broström (MB)
Number of subjects: 119
Study: 35888659

Group type: EXPERIMENTAL
Intervention: 6 cmH2O of PEEP
Number of subjects: 52

Group type: COMPARATOR
Intervention: Zero-PEEP (ZEEP)
Number of subjects: 52
Study: 33228735

Group type: EXPERIMENTAL
Intervention: Postoperative controls by general practitioners (GPs)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Postoperative controls by otolaryngologists
Number of subjects: 200
Study: 34467969

Group type: EXPERIMENTAL
Intervention: Ibrexafungerp (300 mg twice for 1 day)
Number of subjects: 286

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 286
Study: 33582019

Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy
Number of subjects: 64

Group type: COMPARATOR
Intervention: Control group (no convalescent plasma therapy)
Number of subjects: 64
Study: 32410641

Group type: EXPERIMENTAL
Intervention: Acupuncture at the lung meridian
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Acupuncture at the heart meridian
Number of subjects: 48
Study: 36261538

Group type: EXPERIMENTAL
Intervention: Lactobacillus reuteri ATCC PTA 6475 supplementation
Number of subjects: 20
Study: 33901921

Group type: EXPERIMENTAL
Intervention: Granulocyte-colony stimulating factors (G-CSF)
Number of subjects: 458

Group type: COMPARATOR
Intervention: Ciprofloxacin
Number of subjects: 458
Study: 32675553

Group type: EXPERIMENTAL
Intervention: Dome (n=29)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: dV-Trainer (n=30)
Number of subjects: 123

Group type: EXPERIMENTAL
Intervention: DVSS (n=32)
Number of subjects: 123

Group type: COMPARATOR
Intervention: Control (n=32)
Number of subjects: 123
Study: 35592074

Group type: EXPERIMENTAL
Intervention: Multilevel intervention (individual, interpersonal, and community levels)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 0
Study: 34157552

Group type: EXPERIMENTAL
Intervention: Perspective taking (actively imagining another person's mental states)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control instructions
Number of subjects: 0
Study: 35059803

Group type: EXPERIMENTAL
Intervention: 70 kVp tube voltage, Smart mA for noise index (NI) of 36HU, contrast dose rate of 16mgI/kg/s, and DLIR-H
Number of subjects: 100

Group type: COMPARATOR
Intervention: 120 kVp, Smart mA for NI of 25HU, contrast dose rate of 32mgI/kg/s, and 60% ASIR-V
Number of subjects: 100
Study: 32034255

Group type: EXPERIMENTAL
Intervention: Face-to-face intervention group
Number of subjects: 124

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 124
Study: 33915824

Group type: EXPERIMENTAL
Intervention: Movement control exercise group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Muscle strengthening exercise group
Number of subjects: 42

Group type: COMPARATOR
Intervention: Muscle balance exercise group
Number of subjects: 42
Study: 33727377

Group type: EXPERIMENTAL
Intervention: Hydrolyzed cow's milk formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Rice-based formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Soy-based formula
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amino acid-based formula
Number of subjects: 0
Study: 32179212

Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid fish oil emulsion (Om3)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control oil emulsion (Om6)
Number of subjects: 60
Study: 35987298

Group type: EXPERIMENTAL
Intervention: Generic cognitive‐behavioral therapy (CBT) treatment
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Modified (social anxiety) treatment
Number of subjects: 200
Study: 34269262

Group type: EXPERIMENTAL
Intervention: Sevoflurane
Number of subjects: 0

Group type: COMPARATOR
Intervention: Isoflurane
Number of subjects: 0
Study: 33151330

Group type: EXPERIMENTAL
Intervention: Digital CBT (Sleepio)
Number of subjects: 100000

Group type: COMPARATOR
Intervention: No insomnia treatment
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Group CBT
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Pharmacotherapy
Number of subjects: 100000

Group type: EXPERIMENTAL
Intervention: Individual CBT
Number of subjects: 100000
Study: 34714175

Group type: EXPERIMENTAL
Intervention: Laser + Stretch
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Placebo + Stretch
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Stretch
Number of subjects: 215

Group type: EXPERIMENTAL
Intervention: Laser
Number of subjects: 215

Group type: COMPARATOR
Intervention: Control
Number of subjects: 215
Study: 33617181

Group type: EXPERIMENTAL
Intervention: Subcostal anterior quadratus lumborum block
Number of subjects: 55

Group type: COMPARATOR
Intervention: Epidural analgesia
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Patient global assessment
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Duration of PACU stay
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Postoperative duration of hospitalization
Number of subjects: 55
Study: 35324419

Group type: EXPERIMENTAL
Intervention: 3D model
Number of subjects: 118

Group type: COMPARATOR
Intervention: 2D lecture
Number of subjects: 118
Study: 32379474

Group type: EXPERIMENTAL
Intervention: Enriched snack (wakame and carob)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control snack
Number of subjects: 40
Study: 35926901

Group type: EXPERIMENTAL
Intervention: hs-cTn above median (1.5 ng/L)
Number of subjects: 1796

Group type: EXPERIMENTAL
Intervention: IL-6 above median (1.8 ng/L)
Number of subjects: 1796

Group type: EXPERIMENTAL
Intervention: hs-cTn and IL-6 above median in participants with nonobstructive CAD (stenosis 1%-69%)
Number of subjects: 1796
Study: 33559893

Group type: EXPERIMENTAL
Intervention: Ruxolitinib combined with doxorubicin‐etoposide‐methylprednisolone (Ru‐DEP) regimen
Number of subjects: 54
Study: 32598468

Group type: EXPERIMENTAL
Intervention: Nicotine patch plus nicotine gum (8 weeks)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Nicotine patch plus nicotine gum (26 weeks)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Nicotine patch plus gum (both groups)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Lapsers (vs. matched nonlapsers)
Number of subjects: 416
Study: 32507328

Group type: EXPERIMENTAL
Intervention: Voiced High-Frequency Oscillation (VHFO)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Lax Vox technique
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Both exercises (VHFO and Lax Vox)
Number of subjects: 30
Study: 33922745

Group type: EXPERIMENTAL
Intervention: DFGG + Coronal Advancement Flap (CAF)
Number of subjects: 68

Group type: COMPARATOR
Intervention: CTG + Coronal Advancement Flap (CAF)
Number of subjects: 68
Study: 32738019

Group type: EXPERIMENTAL
Intervention: Insulin glulisine (intervention group) for 6 months
Number of subjects: 14

Group type: COMPARATOR
Intervention: Zinc-containing insulin (control group) for 6 months, then switched to insulin glulisine
Number of subjects: 14
Study: 35688566

Group type: EXPERIMENTAL
Intervention: Use of alcohol (measured by AUDIT score)
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Age at first sexual intercourse
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Age of onset of alcohol use
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: AUDIT score
Number of subjects: 319
Study: 34393260

Group type: EXPERIMENTAL
Intervention: Nutritional intervention combined with an intensive 6‐month cardiovascular exercise programme
Number of subjects: 38

Group type: COMPARATOR
Intervention: Control group (postpartum women without pregnancy complications or known cardiovascular risk)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Reference group (postpartum women without pregnancy complications or known cardiovascular risk)
Number of subjects: 38
Study: 33015813

Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum 299v (2 x 10^10 CFU)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study: 33368265

Group type: EXPERIMENTAL
Intervention: Probable bruxism
Number of subjects: 541

Group type: COMPARATOR
Intervention: Periodontitis
Number of subjects: 541
Study: 33066107

Group type: EXPERIMENTAL
Intervention: Bifidobacterium animalis subsp. lactis (BPL1)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 33945163

Group type: EXPERIMENTAL
Intervention: One-session AS cognitive concerns intervention
Number of subjects: 72

Group type: COMPARATOR
Intervention: Single health information control session
Number of subjects: 72